SCHEDULE 13G/A: Vanguard Group Reduces Stake in Annexon Inc. to Below 5%

The Vanguard Group has filed an amended Schedule 13G, disclosing a reduction in its beneficial ownership of Annexon Inc. common stock to 4.9% as of March 31, 2025.

Summary

• The Vanguard Group, a major investment management company, has filed an Amendment No. 1 to its Schedule 13G regarding its beneficial ownership in Annexon Inc.
• As of March 31, 2025, Vanguard beneficially owns 5,379,659 shares of Annexon Inc. common stock.
• This aggregate amount represents 4.9% of Annexon Inc.'s common stock, indicating a reduction from a previous stake that would have been above 5% to trigger the initial Schedule 13G filing.
• Vanguard holds sole voting power over 0 shares, shared voting power over 56,800 shares, sole dispositive power over 5,247,818 shares, and shared dispositive power over 131,841 shares.
• The filing confirms that Vanguard's holdings are for ordinary course of business and not for the purpose of changing or influencing control of Annexon Inc.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the disclosed reduction in beneficial ownership by a major institutional investor, which can be interpreted as a lack of conviction or a reallocation of assets away from the company.

Negatives

• The Vanguard Group has reduced its beneficial ownership in Annexon Inc. to 4.9%, falling below the 5% threshold that typically triggers initial Schedule 13G filings. A reduction in stake by a major institutional investor can be perceived negatively by the market.

Stakeholder Impact

• Shareholders may react to the news of a major institutional investor reducing its stake, potentially leading to negative sentiment or share price volatility.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, Vanguard Group, Annexon Inc., Common Stock, Institutional Ownership, Stake Reduction, SEC Filing